Lucentis (ranibizumab) / Novartis, Roche  >>  Phase 1
Welcome,         Profile    Billing    Logout  

6 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lucentis (ranibizumab) / Roche, Novartis
ChiCTR1800017782: Function of Inflammation Factors in Aflibercept or Ranibizumab Treatment on Alleviating Wet Age-related Macular Degeneration

Completed
1
80
 
Ranibizumab ;Aflibercept
Ningbo 6th Hospital; Ningbo 6th Hospital, General Plan of Medical and Health Research of Health and Family Planning Commission of Zhejiang Province [Grant number:2013 KYA186]
Wet Age-related Macular Degeneration
 
 
NCT03630315: CLN-0046: Treatment of AMD Subjects With OTX-TKI

Active, not recruiting
1
29
RoW
OTX-TKI, Anti-VEGF, aflibercept, bevacizumab, ranibizumab
Ocular Therapeutix, Inc.
Neovascular Age-related Macular Degeneration
12/22
12/22
NCT04884399: Phase I Study to Compare CMAB818 Injection and Lucentis® in Patients With Wet AMD

Completed
1
24
RoW
CMAB818, Ranibizumab Injection, Lucentis®
Shanghai Biomabs Pharmaceutical Co., Ltd.
Wet Age-related Macular Degeneration
12/22
12/22
NCT06205979: Relationship Between Dyslipidemia and The Response of Diabetic Macular Edema to Intravitreal Injection of Anti Vascular Endothelial Growth Factor Agents

Recruiting
1
50
RoW
Ranibizumab Injection [Lucentis], Aflibercept Injection [Eylea]
Sohag University
Diabetic Macular Edema
06/24
06/24
NCT05248334: A Prospective Study of Ranibizumab in the Treatment of Postoperative Recurrent Vitreous Haemorrhage of Diabetic Retinopathy

Recruiting
1
120
RoW
Ranibizumab Injection, Panretinal photocoagulation, PPV
Tianjin Medical University Eye Hospital, Hebei Provincial Eye Hospital, Cangzhou Eye Hospital
Diabetic Retinopathy, Postoperative Recurrent Vitreous Hemorrhage, Pars Plana Vitrectomy, Ranibizumab
12/24
12/24
BURGUNDY, NCT04567303: Study of Zifibancimig in Participants With Neovascular Age-Related Macular Degeneration

Recruiting
1
251
US
Zifibancimig, RO7250284, Ranibizumab, Port Delivery Platform
Hoffmann-La Roche
Macular Degeneration
02/26
12/27

Download Options